OrbiMed’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$25.8K Sell
2022
Q2
$105K Hold
2022
Q1
$85.3M Buy
2018
Q2
Hold
2018
Q1
Hold